Results 151 to 160 of about 10,254 (215)

The Importance of Chemokines Activating CXCR1, CXCR2 and CXCR3 in Tumorigenesis as Potential Therapeutic Targets in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. [PDF]

Cancers (Basel)
Korbecki J, Barczak K, Bosiacka B, Surówka A, Duchnik E, Skarbiński M, Snarski E, Chlubek D, Bosiacki M.   +8 more
europepmc   +1 more source

Diffuse planar xanthomatosis in the setting of monoclonal gammopathy of undetermined significance. [PDF]

J Dermatol
Lenga M, Choi JN.
europepmc   +1 more source

Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis. [PDF]

Blood Cancer J
Maeng CV, Rögnvaldsson S, Einarsson Long T, Brieghel C, Hermansen E, Niemann CU, Grønbæk K, Kristinsson SY, Thorsteinsdóttir S.   +8 more
europepmc   +1 more source

Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis. [PDF]

Blood Cancer J
Maeng CV, Rögnvaldsson S, Einarsson Long T, Brieghel C, Hermansen E, Niemann CU, Grønbæk K, Kristinsson SY, Thorsteinsdóttir S.   +8 more
europepmc   +1 more source

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification. [PDF]

Blood Cancer J
Gor R, Shivakumar J, Surana P, Wei J, Murakhovskaya I, Goldfinger M, Kornblum N, Shapiro L, Shastri A, Gupta R, Levitz D, Konopleva M, Feldman E, Gritsman K, Sica RA, Mantzaris I, Verma A, Cooper D, Janakiram M, Shah N.   +19 more
europepmc   +1 more source

GLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined Significance.

JAMA Netw Open
Chi KY, Song J, Desphande S, Lee PL, Soni A, Gonzales-Uribe A, Lessa Y, Morgan AA, Chang Y, Lin YS, Akman Z, Nouri A, Rossi R, Babapour G, Varrias D, Parker T, Baldassarre LA, Jha A, Muchtar E, Hull SC, Kwan JM, Nanna MG.   +21 more
europepmc   +1 more source

Adopting the new iStopMM-based criteria for light-chain monoclonal gammopathy of undetermined significance: an ongoing debate. [PDF]

Haematologica
Shpitzer D, Cohen YC, Shragai T, Melamed G, Reiner-Benaim A, Avivi I.   +5 more
europepmc   +1 more source

Bone Status in Patients with Monoclonal Gammopathy of Undetermined Significance: A Case-Control Study.

Ann Afr Med
Taoubane L, Jennane S, El Hani H, Majjad A, Toufik H, El Ouardi N, Doghmi K, Achemlal L, El Maghraoui A, Bezza A.   +9 more
europepmc   +1 more source

A Rare Case of Hereditary Factor XI Deficiency Accompanied by Lupus Anticoagulant in an Adult Patient with Monoclonal Gammopathy of Undetermined Significance. [PDF]

Intern Med
Liu H.
europepmc   +1 more source

Rapid progression of monoclonal gammopathy of undetermined significance to cardiac amyloidosis with intracardiac thrombus: Unveiling via cardiac magnetic resonance. [PDF]

Radiol Case Rep
Kayed HAA, Hamam Y, Kayed NA, Alajarmeh AO.   +3 more
europepmc   +1 more source